Skip to content

Clinical trials

Completed Breast Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Russia Clear all

150 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20014
20024
20035
20044
20054
200613
20078
200810
20099
20106
201112
201213
20139
20147
20154
20163
20171
20188
20197
20202
20214
20226
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed150

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche27
Novartis Pharmaceuticals20
Pfizer10
Tomsk National Research Medical Center of the Russian Academy of Sciences10
AstraZeneca9
Eli Lilly and Company7
GlaxoSmithKline5
Biocad4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Puma Biotechnology, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms150
Neoplasm Metastasis19
Neoplasms12
Neutropenia5
Prostatic Neoplasms4
Sarcoma3
Triple Negative Breast Neoplasms3
Breast Diseases2
Febrile Neutropenia2
Melanoma2

Trials

Showing 1 to 25 of 150. Each trial links to its page on Pharma Observatory.

50 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.